Journal of Atherosclerosis and Thrombosis

Scope & Guideline

Shaping the future of cardiovascular care with cutting-edge insights.

Introduction

Delve into the academic richness of Journal of Atherosclerosis and Thrombosis with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1340-3478
PublisherJAPAN ATHEROSCLEROSIS SOC
Support Open AccessNo
CountryJapan
TypeJournal
Convergefrom 1994 to 1998, from 2000 to 2024
AbbreviationJ ATHEROSCLER THROMB / J. Atheroscler. Thromb.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressNICHINAI-KAIKAN B1, 3-28-8 HONGO BUNKYO-KU, TOKYO 113-0033, JAPAN

Aims and Scopes

The Journal of Atherosclerosis and Thrombosis focuses on providing a comprehensive platform for research related to cardiovascular diseases, particularly those involving atherosclerosis and thrombosis. It aims to advance knowledge in the field through the publication of high-quality studies that explore various aspects of cardiovascular health, risk factors, and treatment strategies.
  1. Atherosclerosis Mechanisms:
    The journal emphasizes research on the biological mechanisms underlying atherosclerosis, including lipid metabolism, inflammation, and plaque formation.
  2. Thrombosis and Vascular Health:
    It covers studies related to thrombotic events, their risk factors, and the impact on vascular health, emphasizing the interplay between thrombosis and atherosclerosis.
  3. Clinical Studies and Trials:
    The journal publishes clinical research, including randomized controlled trials and observational studies, that evaluate the effectiveness of therapeutic interventions for cardiovascular diseases.
  4. Epidemiological Research:
    It includes epidemiological studies that assess the prevalence, risk factors, and outcomes related to cardiovascular diseases, particularly in specific populations.
  5. Innovative Diagnostic and Therapeutic Approaches:
    The journal showcases advancements in diagnostic techniques and therapeutic approaches, including pharmacological and non-pharmacological interventions for managing cardiovascular risk.
The Journal of Atherosclerosis and Thrombosis is witnessing emerging themes that reflect the evolving landscape of cardiovascular research. These trends highlight the importance of personalized medicine, novel therapeutic targets, and the integration of lifestyle factors into cardiovascular health management.
  1. Precision Medicine and Genetic Research:
    There is a growing emphasis on precision medicine, with studies exploring genetic predispositions to cardiovascular diseases and how individualized treatment plans can improve outcomes.
  2. Impact of Lifestyle Factors:
    Research examining the influence of lifestyle factors such as diet, physical activity, and psychosocial elements on cardiovascular health is increasingly prevalent, reflecting a holistic approach to prevention and treatment.
  3. Novel Therapeutic Agents:
    The journal is seeing a rise in studies related to novel therapeutic agents, including PCSK9 inhibitors, SGLT2 inhibitors, and other emerging pharmacological treatments that target specific pathways in atherosclerosis.
  4. Interdisciplinary Approaches:
    Emerging interdisciplinary research that combines cardiology with fields such as endocrinology, nephrology, and nutrition is gaining traction, underscoring the complex nature of cardiovascular health.
  5. Artificial Intelligence and Big Data in Cardiovascular Research:
    The integration of artificial intelligence and big data analytics in cardiovascular research is a rapidly growing area, focusing on predictive modeling and personalized treatment strategies.

Declining or Waning

While the Journal of Atherosclerosis and Thrombosis continues to publish a wide range of studies, some themes appear to be declining in prominence. This can be attributed to shifts in research focus or advancements in understanding that make certain areas less central to current cardiovascular research.
  1. Traditional Lipid Management:
    Research centered solely on traditional lipid management strategies, such as statin therapy, is becoming less frequent as new therapeutic agents and holistic approaches gain attention.
  2. Basic Science of Lipoproteins:
    There is a noticeable decline in studies focused exclusively on the basic science of lipoproteins without clinical applications, as the focus shifts towards translational research that connects laboratory findings to clinical outcomes.
  3. Single-Factor Risk Assessment:
    Research that evaluates cardiovascular risk based on single factors (e.g., cholesterol levels alone) is waning in favor of more comprehensive models that consider multiple risk factors and their interactions.

Similar Journals

Cardiology and Therapy

Driving excellence in cardiology and therapeutic solutions.
Publisher: SPRINGER LONDON LTDISSN: 2193-8261Frequency: 1 issue/year

Cardiology and Therapy, published by SPRINGER LONDON LTD, is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. With an ISSN of 2193-8261 and an E-ISSN of 2193-6544, this esteemed journal has been at the forefront of disseminating high-quality research since its inception in 2012. It has achieved an impressive Q1 ranking in the 2023 Cardiology and Cardiovascular Medicine category, reflecting its commitment to excellence and relevance in the field. Spanning a wide array of topics—from clinical studies to cutting-edge therapeutic interventions—the journal aims to foster knowledge exchange among researchers, clinicians, and healthcare professionals. In addition, its position in the 72nd percentile of Scopus rankings underscores its global impact and contribution to the cardiovascular research community. With open access options, Cardiology and Therapy ensures that its content is widely accessible, promoting the sharing of vital findings that can influence clinical practice and improve patient outcomes.

CIRCULATION RESEARCH

Elevating knowledge in the dynamic field of cardiovascular medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7330Frequency: 24 issues/year

CIRCULATION RESEARCH is a premier journal dedicated to advancing the field of cardiovascular science, focusing on innovative research in cardiology and physiology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of cardiovascular research since its inception in 1953, maintaining rigorous standards of scholarly excellence. With an impressive impact factor and ranking in the top quartiles for both Cardiology and Cardiovascular Medicine (Q1) and Physiology (Q1), it holds a significant position in the Scopus database. This journal features cutting-edge studies aimed at understanding the mechanisms of cardiovascular health and disease, promoting the translation of research into clinical practice. Weekly issues provide practitioners and researchers alike with vital insights to keep abreast of the latest developments. Although it does not offer open access, CIRCULATION RESEARCH remains vital for professionals striving to enhance their knowledge and impact in the ever-evolving landscape of cardiovascular medicine.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Advancing cardiovascular knowledge through groundbreaking research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1079-5642Frequency: 12 issues/year

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

Cardiovascular Innovations and Applications

Bridging the gap between research and practice in cardiovascular medicine.
Publisher: COMPUSCRIPTISSN: 2009-8618Frequency: 1 issue/year

Cardiovascular Innovations and Applications is a premier open-access journal dedicated to advancing knowledge in the field of cardiovascular medicine. Published by COMPUSCRIPT since 2016, this journal provides a platform for the dissemination of innovative research and applications that address crucial topics in cardiology, aiming to bridge the gap between clinical practice and cutting-edge research. With an ISSN of 2009-8618 and an E-ISSN of 2009-8782, it operates on a global scale, facilitating access to high-quality content without financial barriers. The journal is positioned within the Medicine - Cardiology and Cardiovascular Medicine category, and its current Scopus rank of #321/387 reflects its potential for growth and influence in the academic community, being in the 17th percentile. Researchers, healthcare professionals, and students will find Cardiovascular Innovations and Applications an invaluable resource in their quest for the latest findings and advancements in cardiovascular health and treatment methodologies.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Advancing Cardiovascular Knowledge for a Healthier Tomorrow
Publisher: ELSEVIER SCIENCE INCISSN: 0735-1097Frequency: 50 issues/year

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, the esteemed publication of Elsevier Science Inc, stands as a premier platform for advancing knowledge in the field of cardiology and cardiovascular medicine. With an impressive impact factor reflecting its prominence—ranked Q1 in its category for 2023 and occupying the 4th position out of 387 in the Scopus listings, firmly placing it in the 99th percentile—this journal is essential for researchers, clinicians, and students alike. Since its inception in 1983, it has continuously provided a vital space for high-quality research and innovative clinical practices, driving forward our understanding of cardiovascular health. While access options are not open, the value of the cutting-edge articles published here cannot be overstated, as they foster collaboration and inform better patient care across the globe. As part of its ongoing commitment to excellence, the journal solicits submissions of original research, reviews, and clinical studies that contribute meaningfully to the field and engage its diverse readership.

HYPERTENSION RESEARCH

Pioneering research at the intersection of cardiology and physiology.
Publisher: SPRINGERNATUREISSN: 0916-9636Frequency: 12 issues/year

HYPERTENSION RESEARCH, published by SpringerNature, serves as a premier platform in the field of Cardiology and Cardiovascular Medicine, Internal Medicine, and Physiology. Since its inception in 1992, the journal has built a substantial reputation, currently ranked in the second quartile (Q2) across several categories in 2023, reflecting its influence and high-quality contributions to medical research. With a focus on hypertension, the journal aims to disseminate vital research findings, clinical studies, and innovative treatment strategies to a diverse audience of researchers, healthcare professionals, and students, fostering knowledge exchange in the management of hypertensive conditions. Although it is not an Open Access journal, it offers comprehensive access to its extensive archive of valuable resources, ensuring that critical advancements in the understanding of hypertension are both accessible and impactful. HYPERTENSION RESEARCH is not only essential for those directly involved in cardiovascular and internal medicine practices but also for interdisciplinary scholars who are looking to explore the intersections of physiology and other biomedical fields in their work.

Circulation-Cardiovascular Interventions

Elevating Standards in Cardiovascular Medicine and Practice.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1941-7640Frequency: 12 issues/year

Circulation-Cardiovascular Interventions, published by LIPPINCOTT WILLIAMS & WILKINS, is a premier journal in the field of cardiology and cardiovascular medicine, recognized for its commitment to advancing the understanding and treatment of cardiovascular diseases. With a robust Impact Factor and ranking in the top 10% of its category, it serves as an essential resource for researchers, clinicians, and students seeking to stay at the forefront of cardiovascular intervention developments. This esteemed journal covers a range of topics, including innovative therapeutic strategies, cutting-edge clinical trials, and comprehensive reviews that inform clinical practice and influence guidelines. Since its inception in 2008, and extending through 2024, Circulation-Cardiovascular Interventions has published pivotal research that shapes the landscape of cardiovascular care in the United States and beyond. Its commitment to high-quality publications makes it an invaluable platform for sharing knowledge and fostering collaboration within the global medical community.

ANNALS OF INTERNAL MEDICINE

Shaping the Future of Medicine with Impactful Scholarship
Publisher: AMER COLL PHYSICIANSISSN: 0003-4819Frequency: 12 issues/year

ANNALS OF INTERNAL MEDICINE, published by the American College of Physicians, stands as one of the leading journals in the field of internal medicine, with an impressive impact factor that underscores its significance in academic discourse. Since its inception in 1945, this esteemed journal has maintained a steadfast commitment to publishing high-quality research that spans a broad spectrum of internal medicine, making substantial contributions to clinical practice and health policy. With a current ranking of #5 out of 167 in the field of Internal Medicine and a remarkable 97th percentile ranking in literature, the ANNALS OF INTERNAL MEDICINE is recognized as a vital resource for researchers, healthcare professionals, and students alike. Although it operates under a traditional subscription model, the journal continually emphasizes the importance of disseminating robust clinical trials, systematic reviews, and expert commentaries that advance medical knowledge and practice. Its quartile rankings in Q1 for both Internal Medicine and Miscellaneous Medicine highlight its role in shaping the future of healthcare through rigorous and impactful scientific inquiry.

CARDIOVASCULAR RESEARCH

Elevating knowledge in cardiovascular medicine.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

JOURNAL OF CARDIOVASCULAR SURGERY

Exploring breakthroughs in cardiac medicine.
Publisher: EDIZIONI MINERVA MEDICAISSN: 0021-9509Frequency: 6 issues/year

JOURNAL OF CARDIOVASCULAR SURGERY, published by EDIZIONI MINERVA MEDICA, stands as a pivotal resource in the field of cardiovascular medicine and surgical practices. With a rich history dating back to 1960 and ongoing contributions scheduled until 2024, this esteemed journal provides a platform for the dissemination of innovative research in cardiology and surgical techniques. Registered under ISSN 0021-9509 and E-ISSN 1827-191X, it holds a commendable standing reflected in its Scopus rankings, placing it in the second quartile for both cardiology and cardiovascular medicine, as well as surgery. Despite not currently offering Open Access, the journal remains a vital source for practitioners and researchers alike, facilitating a deeper understanding of advancing methodologies and clinical practices in cardiovascular surgery. The journal is headquartered in Turin, Italy, and is committed to nurturing academic excellence within the community, making it an essential read for professionals, researchers, and students striving to enhance their knowledge and expertise in this critical field.